Pharmacokinetcis of Tirabrutinib in combination with single dose rifampin and multiple dose rifampin in healthy volunteers

Trial Profile

Pharmacokinetcis of Tirabrutinib in combination with single dose rifampin and multiple dose rifampin in healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Apr 2017

At a glance

  • Drugs Tirabrutinib (Primary) ; Rifampicin
  • Indications B cell lymphoma
  • Focus Pharmacokinetics
  • Most Recent Events

    • 05 Apr 2017 Results of pharmacodynamic biomarkers presented at the 108th Annual Meeting of the American Association for Cancer Research
    • 05 Apr 2017 New trial record
    • 18 Mar 2017 Results presented at the 118th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top